Ads
related to: astrazeneca
Search results
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 7 hours agoA decade ago, as British drugmaker AstraZeneca fought off a hostile takeover bid by Pfizer, CEO Pascal Soriot made a big promise: The company, he said,...
AstraZeneca kicks off ‘new era of growth’ with $80 billion sales goal by 2030
Market Watch· 11 hours agoThe Anglo-Swedish pharmaceutical company’s CEO Pascal Soriot said the announcement marks the start...
AstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline Expansion Why Is ...
Benzinga· 8 hours agoTuesday, AstraZeneca Plc AZN announced its ambitious plan to increase its total revenue to $80...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
The Dispatch via Yahoo News· 5 days ago(Photo Illustration by Jakub Porzycki/NurPhoto/Getty Images) Since last week, hundreds of social...
AstraZeneca aims increase its annual revenue by 75% in its post-COVID era
Quartz· 5 hours agoCambridge, U.K.-based pharmacuetical giant AstraZeneca announced an ambitious sales goal for the end of this decade, just as it pulls it COVID-19 vaccines off the shelves.
'New era of growth': AstraZeneca sets out bold plans for $80bn revenues by 2030
Evening Standard via Yahoo Finance· 10 hours agoThe biggest company on London’s stock market, AstraZeneca, set out bold plans today for what it’s...
FTSE 100 Live 21 May: Index rallies after early fall, IMF upgrades UK, AstraZeneca sets $80bn target
Evening Standard via Yahoo Finance· 4 hours agoThe FTSE 100 is close to where it started the day, despite losing almost 50 points in early trading....
AstraZeneca aims for $80 billion in total revenue by 2030 By Reuters
Investing.com· 7 hours agoThe Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier...
AstraZeneca to harness China's 'explosion' of innovation to boost cell therapy R&D
FierceBiotech· 7 hours agoAstraZeneca’s growing presence in China will play a key role in the Big Pharma’s cell therapy...
AstraZeneca Targets $80 Billion Revenue by 2030 Through Pipeline Expansion
The Wall Street Journal· 12 hours agoAstraZeneca has set out a new revenue target as it aims to bolster its investment in technologies...